SCHEMBL22628601

SCHEMBL22628601

COc1ccc2c(c1)CCC(c1ccccc1C)C2=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP24A1 Q07973 6/20 0.62
CYP26A1 O43174 3/20 0.62
CYP27A1 Q02318 3/20 0.54
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.50
HPGD P15428 1/20 0.50
DRD2 P14416 2/20 0.48
HTR2A P28223 2/20 0.48
HTR2C P28335 2/20 0.48
HTR2B P41595 2/20 0.48
SIGMAR1 Q99720 2/20 0.48
CYP19A1 P11511 2/20 0.48
ACHE P22303 3/20 0.46
MIF P14174 1/20 0.44
NPC1 O15118 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31053075 1.00 CYP24A1 (0.62) CYP24A1CYP26A1CYP27A1MAPTMEN1
SCHEMBL4366122 0.83 CYP24A1 (0.60) CYP24A1CYP26A1CYP27A1MAPTALDH1A1
SCHEMBL15874767 0.83 CYP24A1 (0.60) CYP24A1CYP26A1CYP27A1MAPTALDH1A1
SCHEMBL903653 0.82 CYP24A1 (0.50) CYP24A1CYP26A1CYP27A1MAPTALDH1A1
SCHEMBL5917029 0.82 CYP24A1 (0.50) CYP24A1CYP26A1CYP27A1MAPTMEN1
SCHEMBL4800651 0.81 CYP19A1 (0.55) DRD2HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL21185074 0.80 CYP19A1 (0.57) CYP24A1CYP26A1MAPTMEN1ALDH1A1
SCHEMBL6669546 0.80 CYP24A1 (0.53) CYP24A1CYP26A1CYP27A1DRD2HTR2A
SCHEMBL15263331 0.79 CYP24A1 (0.51) CYP24A1CYP26A1CYP27A1MAPTALDH1A1
SCHEMBL4602048 0.79 DDB1 (0.56) CYP24A1CYP26A1CYP27A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497386-B2 Estrogen receptor-modulating compounds RADIUS PHARMACEUTICALS, INC. (US) 2025-12-16 US disclosed
US-20240308986-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS RADIUS PHARMACEUTICALS, INC. 2024-09-19 US disclosed
US-12018019-B2 Estrogen receptor-modulating compounds RADIUS PHARMACEUTICALS, INC. (US) 2024-06-25 US disclosed
US-12018019-B2 Estrogen receptor-modulating compounds RADIUS PHARMACEUTICALS, INC. (US) 2024-06-25 US disclosed
US-20220332704-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS RADIUS PHARMACEUTICALS, INC. 2022-10-20 US disclosed
US-11384068-B2 Estrogen receptor-modulating compounds RADIUS PHARMACEUTICALS, INC. (US) 2022-07-12 US disclosed
US-11384068-B2 Estrogen receptor-modulating compounds RADIUS PHARMACEUTICALS, INC. (US) 2022-07-12 US disclosed
CN-112105607-A Estrogen receptor modulating compounds 雷迪厄斯制药公司 2020-12-18 CN disclosed
US-20200347032-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS RADIUS HEALTH, INC. 2020-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200347032-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885
US-20240308986-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885
US-20220332704-A1 ESTROGEN RECEPTOR-MODULATING COMPOUNDS ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885
US-11384068-B2 Estrogen receptor-modulating compounds ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885
US-12018019-B2 Estrogen receptor-modulating compounds ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885
US-12497386-B2 Estrogen receptor-modulating compounds ESR2, GPER1, ESR1 CYP24A1 117/4885CYP26A1 226/4885CYP27A1 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.